Activity-guided isolation of scopoletin and isoscopoletin, the inhibitory active principles towards CCRF-CEM leukaemia cells and multi-drug resistant CEM/ADR5000 cells, from Artemisia argyi

Planta Medica

Volumn 72, Issue 9, 2006, Pages 862-864

  Adams, Michael ^a   Efferth, Thomas ^b   Bauer, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARTEMISIA ARGYI EXTRACT; DOXORUBICIN; HERBACEOUS AGENT; ISOSCOPOLETIN; PACLITAXEL; PLANT EXTRACT; SCOPOLETIN; UNCLASSIFIED DRUG; VINCRISTINE;

ARTEMISIA; ARTICLE; BIOASSAY; CANCER INHIBITION; CELL PROLIFERATION; CROSS RESISTANCE; DRUG INHIBITION; DRUG ISOLATION; FRACTIONATION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; PLANT LEAF;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARTEMISIA; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMICAL FRACTIONATION; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; HUMANS; LEUKEMIA; SCOPOLETIN;

ARTEMISIA ARGYI;

EID: 33746965536     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947165     Document Type: Article

References (13)

1. Pharmacopoeia of the Peoples Republic of China (English Edition). Beijing: Chemical Industry Press, 2000: p 73
2. Tang W, Eisenbrand G. Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine. Berlin/Heidelberg: Springer Verlag, 1992: p 175-8
3. Efferth T, Davey M, Olbrich A, Ruecker G, Gebhart E, Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukaemia cells. Blood Cells Mol Dis 2002; 28: 160-8
4. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The antimalarial artesunate is also a potent anticancer drug. Int J Oncol 2001; 18: 767-73
5. Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO et al. Molecular modes of action of artesunate in tumour cell lines. Mol Pharmacol 2003; 64: 382-94
6. Kim KH, Jung DJ, Min TJ, Park SW. Cytotoxicity of Artemisia argyi extract against h9 (ATCC HTB 176) cell and antioxidant enzyme activities. Yakhak Hoechi 1999; 43: 598-605
7. Lee SH, Kim HK, Seo JM, Kang HM, Kim JH, Son KH et al. Arteminolides B, C, and D, new inhibitors of farnesyl protein transferase from Artemisa argyi. J Org Chem 2002; 67: 7670-5
8. Seo JM, Kang HM, Son KH, Kim JH, Lee CW, Kim HM et al. Antitumor activity of flavones isolated from Artimisia argyi. Planta Med 2003; 69: 218-22
9. Nagasuki T, Nakashima M, Koichiro K. Antimutagens in Gaiyou (Artemisia argyi Levl. et Vant). J Agric Food Chem 2000; 48: 3256-66
10. Masayuki Y, Hiromi S, Hisashi M, Johji Y, Nobutoshi M. Bioactive constituents of Chinese natural medicines. I. New sesquiterpene ketones with vasorelaxant effect from Chinese Moxa, the processed leaves of Artemisia argyi Levl. et Vant.: moxartenone and moxartenolide. Chem Pharm Bull 1996; 44: 1656-62
11. Aoife L, O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Design 2004; 10: 3797-811
12. Liu XL, Zhang L, Fu XL, Chen K, Quian BC. Effect of scopoletin on PC3 cell proliferation and apoptosis. Acta Pharmacol Sin 2001; 22: 929-33
13. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y. The antiproliferative effect of coumarins on several cancer cell lines. Anticancer Res 2001; 21: 917-23